<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01805700</url>
  </required_header>
  <id_info>
    <org_study_id>B091217</org_study_id>
    <nct_id>NCT01805700</nct_id>
  </id_info>
  <brief_title>Effects of Acute Intake of Caffeinated Beverages in Type 1 Diabetes</brief_title>
  <acronym>REDBULL</acronym>
  <official_title>Effects of Acute Intake of Caffeine Enhanced Energy Drinks on Blood Glucose, Some Physiological Parameters and Cognitive Performance in Patients With Type 1 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Royal Bournemouth Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Royal Bournemouth Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this pilot study is to determine the impact of caffeine-enhanced energy drinks on
      blood glucose excursion on heart rate, blood pressure, cardiac output and cognitive
      performance in patients with type 1 diabetes.

      Knowledge acquired may inform a wider study of the impact of these drinks.

      This is a randomised, cross over blinded study in which all participants will participate in
      the 3 arms of the study.

      The study will consist of 3 phases, each lasting 3 days. A different study drink will be
      administered during each phase. There will be an initial screening visit and a pre- study
      visit before each study phase. Each participant will make 10 visits to the research centre.

      There will be a week wash out period between each study phase. Prior to each study phase,
      there will be a 3 day caffeine and alcohol abstinence run-in period.

      Study drinks will be matched for taste and volume (as far as possible) and will be
      administered by the use of opaque cups, lids and straws to enable double-blind randomisation
      for both researcher and participants. Administration of the study drink to participants will
      be based on Latin squares to provide a balanced treatment order.

      During the 3 days study period; participants will be required to abstain from all other
      caffeine containing beverages or confectioneries.

      The secondary aim is to determine if tolerance to cardiovascular effects of caffeine-enhanced
      energy drinks is developed following acute short term ingestion.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in blood glucose level in all patients as a measure of tolerability</measure>
    <time_frame>Day 1, Day 2 and Day 3</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The effects on certain mood states, e.g. energetic arousal, tense arousal and hedonic tone following the consumption of caffeinated energy drinks in comparison with caffeine free glucose in patients with type 1 diabetes</measure>
    <time_frame>Day 1, day 2 and day 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in reaction time and digit symbol substitution test score</measure>
    <time_frame>Day 1, day 2 and day 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in heart rate, systolic and diastolic blood pressure in all patients.</measure>
    <time_frame>Day 1, day 2 and day 3</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>Regular caffeine enhanced energy drink</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Regular caffeine enhanced energy drink (containing 240mg caffeine &amp; 84g glucose) e.g. regular red bull cans (x3)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diet Caffeine enhanced energy drink</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diet Caffeine enhanced energy drink ( containing 240mg of caffeine alone) e.g. Red Bull light)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucose drink</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Glucose drink (containing 84g glucose alone)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Caffeine enhanced energy drink</intervention_name>
    <description>Comparison of different energy drinks</description>
    <arm_group_label>Regular caffeine enhanced energy drink</arm_group_label>
    <arm_group_label>Diet Caffeine enhanced energy drink</arm_group_label>
    <other_name>Red Bull</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glucose drink</intervention_name>
    <description>Glucose drink (containing 84mg glucose alone)</description>
    <arm_group_label>Glucose drink</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female adults aged â‰¥18 years

          -  Confirmed diagnosis of Type 1 diabetes of more than one year duration

          -  Participants who use multiple daily injections of basal and meal-time analogue
             insulin.

          -  Ability to perform daily finger stick measurements of blood glucose levels

          -  Adequate contraceptive control

          -  Provision of informed consent

        Exclusion Criteria:

          -  Hypoglycaemia unawareness

          -  Coronary heart disease

          -  Cardiac arrhythmia

          -  Structural heart lesions,

          -  Autonomic neuropathy

          -  Psychiatry illness,

          -  Epilepsy

          -  Migraine

          -  Caffeine intolerance

          -  Unable to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tolulope Olateju, MRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust</name>
      <address>
        <city>Bournemouth</city>
        <state>Dorset</state>
        <zip>BH7 7DW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2013</study_first_submitted>
  <study_first_submitted_qc>March 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2013</study_first_posted>
  <last_update_submitted>March 4, 2013</last_update_submitted>
  <last_update_submitted_qc>March 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 6, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>type 1</keyword>
  <keyword>diabetes</keyword>
  <keyword>caffeine-enhanced energy drink</keyword>
  <keyword>cardiac output</keyword>
  <keyword>glucose</keyword>
  <keyword>cognitive performance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caffeine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

